Fetal Calprotectin Level in Suspected Intra-Amniotic Infection
Elevated fetal calprotectin levels in amniotic fluid indicate intra-amniotic infection and should prompt immediate delivery planning, as concentrations are significantly higher in true infection (median 101.6 µg/mL) compared to sterile inflammation (median 9.2 µg/mL), and correlate with delivery within 7 days.
Understanding Calprotectin in the Fetal Compartment
Calprotectin is a neutrophil-derived inflammation marker that distinguishes true intra-amniotic infection from sterile inflammation. 1
Key diagnostic thresholds from the evidence:
- Intra-amniotic infection: median calprotectin 101.6 µg/mL 1
- Sterile intra-amniotic inflammation: median 9.2 µg/mL 1
- Intra-amniotic colonization: median 2.6 µg/mL 1
- Normal amniotic fluid: median 4.6 µg/mL 1
Importantly, fetal calprotectin (measured in umbilical cord blood) does NOT elevate in maternal conditions like preeclampsia, confirming its specificity for fetal compartment infection rather than maternal systemic inflammation. 2, 3
Clinical Management Algorithm
When Elevated Amniotic Fluid Calprotectin is Detected:
1. Confirm the diagnosis of membrane rupture and assess for clinical infection signs: 4
- Maternal fever (daily temperature monitoring)
- Maternal tachycardia or fetal tachycardia
- Uterine tenderness
- Malodorous or purulent vaginal discharge
- Maternal leukocytosis
2. Correlate with IL-6 levels if available:
- IL-6 ≥745 pg/mL defines intra-amniotic inflammation 1
- Combined elevation of both calprotectin and IL-6 strongly indicates infection requiring intervention 1
3. Assess gestational age and viability: 5, 4
- ≥24 weeks gestation: Proceed with delivery planning
- <24 weeks (previable): Counsel regarding extremely poor prognosis with infection; neonatal resuscitation typically not pursued 5
4. Initiate immediate management for viable gestations:
- Administer intravenous antibiotics immediately - do not delay for culture results, as elevated calprotectin predicts delivery within 7 days 1
- Give antenatal corticosteroids if between 24-34 weeks for fetal lung maturity 4
- Administer magnesium sulfate for neuroprotection if 24+0 to 29+6 weeks 4
- Plan delivery - expectant management is contraindicated with confirmed infection 5
Critical Pitfalls to Avoid
Do not confuse elevated maternal serum calprotectin with amniotic fluid calprotectin. Maternal serum calprotectin elevates in preeclampsia and normal pregnancy but does NOT reflect fetal infection status. 2, 3 Only amniotic fluid calprotectin (obtained via amniocentesis) provides diagnostic information about intra-amniotic infection. 1
Do not pursue serial amnioinfusions or amniopatch procedures when infection is present. These interventions have not shown benefit in reducing perinatal morbidity and are contraindicated with active infection. 5
Recognize that bacteria may be present in the amnio-chorionic niche even with sterile amniotic fluid cultures. The sterile inflammation group showed relatively more bacteria in this space, suggesting occult infection may drive inflammation. 1
Prognostic Implications
Higher amniotic fluid calprotectin concentrations correlate with:
- Earlier delivery (negative correlation with gestational age at delivery, rho = 0.32) 1
- Delivery within 7 days (p = 0.003) 1
- Worse neonatal outcomes due to prematurity and sepsis 4
The median latency after PPROM with infection is significantly shortened, making prompt intervention essential to optimize maternal safety while maximizing gestational age for fetal benefit. 4